Zenas BioPharma
Kate Didio is an experienced professional in clinical project management and operations, currently serving as Sr. Director of Clinical Project Management at Zenas BioPharma since March 2024. Previously, Kate owned and operated K Didio Consulting, LLC from May 2013 to March 2024. Kate's extensive experience includes senior roles at Sirtris Pharmaceuticals (a GSK company) and Surface Logix, as well as positions at Molecular Insight Pharmaceuticals and Sepracor Inc. Kate began a career in clinical oversight at Boston Biostatistics as Regional CRA Manager. Academic credentials include an MBA in Business Administration from Simmons College, a BS in Health Care Administration from Emmanuel College, and an AS in Nursing from The Sage Colleges.
This person is not in any teams
This person is not in any offices
Zenas BioPharma
6 followers
Zenas BioPharma is a cross-border (China-USA-based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through its successful business development strategy.